Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_assertion type Assertion NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_head.
- NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_assertion description "[The high prevalence of the silencing of RELN pathway components and its reversal by histone deacetylase inhibitors suggest the importance of this pathway as a diagnostic and therapeutic target for pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_provenance.
- NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_assertion evidence source_evidence_literature NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_provenance.
- NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_assertion SIO_000772 16472607 NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_provenance.
- NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_assertion wasDerivedFrom befree-20140225 NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_provenance.
- NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_assertion wasGeneratedBy ECO_0000203 NP472465.RA0kvwW7uFlDj67BWM1fyxFw4efpDJ6zhfis-xHKPbxQo130_provenance.